Sign In
Buy FBT
$247.54
-2.05 (-0.82%)
At Close: Jul 13, 2026
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?
03:30pm, Sunday, 12'th Jul 2026
First Trust NYSE Arca Biotechnology Index Fund offers a more concentrated portfolio with only 30 holdings compared to the 248 positions in iShares Biotechnology ETF iShares Biotechnology ETF is the la
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
07:21am, Friday, 10'th Jul 2026
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?
06:04pm, Wednesday, 08'th Jul 2026
Invesco Pharmaceuticals ETF has a higher 5-year growth total of $1,563 compared to $1,480 for First Trust NYSE Arca Biotechnology Index Fund First Trust NYSE Arca Biotechnology Index Fund is more affo
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 02'nd Jul 2026
Launched on June 19, 2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
01:13pm, Thursday, 04'th Jun 2026
Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration-key factors shaping their long-term investor appeal.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
07:21am, Thursday, 07'th May 2026
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Tuesday, 28'th Apr 2026
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
07:22am, Tuesday, 03'rd Mar 2026
A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update
01:03am, Tuesday, 03'rd Mar 2026
First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT - Get Free Report) was the recipient of a large growth in short interest in February. As of February 13th, there was short interest totalin
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:20am, Tuesday, 24'th Feb 2026
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned
07:55am, Friday, 09'th Jan 2026
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak.
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
07:21am, Thursday, 01'st Jan 2026
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:22am, Thursday, 25'th Dec 2025
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks
09:51am, Tuesday, 18'th Nov 2025
Biotech ETFs PBE and FBT saw trading volumes soar to over four times their averages, signaling rising interest amid a down day for major indexes.
